Highlights include a link between migraines and T2DM risk in women; fasting-evoked hypoglycemia being overlooked; and how gut microbiome influences the metabolism of diabetes drugs.
Endocrinology Month in Review: April 2024
Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations
ACP's New Type 2 Diabetes Guidance Recommends SGLT2is, GLP-1 RAs as Second-Line to Metformin
Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
SMART-C Meta-Analysis: SGLT2 Inhibitors Reduce Cardiovascular Events
Insulin Glargine Biosimilar Demonstrates Bioequivalence to Originator for Type 2 Diabetes